Integrin beta3 Antibody from Cell Signaling Technology

The integrin beta3 antibody is reactive with several species, including humans, mice, rats, non-human primates, and bovines.

Yes, the integrin beta3 antibody has been utilized in Western blot applications, as evidenced by its use in various studies, including those investigating osteoclast differentiation and tumor growth mechanisms (bae2017, caron2023).

Indeed, the integrin beta3 antibody has been shown to play a role in cancer research, particularly in studies examining its involvement in tumor growth and angiogenesis. For instance, it has been implicated in signaling pathways that regulate tumor progression and immune checkpoint molecules like PD-L1 (caron2023, ellison2015).

Yes, the integrin beta3 antibody has been referenced in studies focused on osteoclastogenesis, highlighting its role in metabolic reprogramming during osteoclast differentiation and its potential as a therapeutic target in osteoporosis (bae2017, zeng2015).